261 related articles for article (PubMed ID: 36690175)
21. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
Kriegel C; Attarwala H; Amiji M
Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
[TBL] [Abstract][Full Text] [Related]
22. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids.
Nimesh S; Gupta N; Chandra R
J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455
[TBL] [Abstract][Full Text] [Related]
23. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
Chen MC; Sonaje K; Chen KJ; Sung HW
Biomaterials; 2011 Dec; 32(36):9826-38. PubMed ID: 21925726
[TBL] [Abstract][Full Text] [Related]
24. Solid nanoparticles for oral antimicrobial drug delivery: a review.
Raza A; Sime FB; Cabot PJ; Maqbool F; Roberts JA; Falconer JR
Drug Discov Today; 2019 Mar; 24(3):858-866. PubMed ID: 30654055
[TBL] [Abstract][Full Text] [Related]
25. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
Ball RL; Bajaj P; Whitehead KA
Sci Rep; 2018 Feb; 8(1):2178. PubMed ID: 29391566
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in oral insulin delivery technologies.
Zhang E; Zhu H; Song B; Shi Y; Cao Z
J Control Release; 2024 Feb; 366():221-230. PubMed ID: 38161033
[TBL] [Abstract][Full Text] [Related]
27. Oral peptide delivery: Translational challenges due to physiological effects.
Tyagi P; Pechenov S; Anand Subramony J
J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
[TBL] [Abstract][Full Text] [Related]
28. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.
Desai D; Prabhakar N; Mamaeva V; Karaman DŞ; Lähdeniemi IA; Sahlgren C; Rosenholm JM; Toivola DM
Int J Nanomedicine; 2016; 11():299-313. PubMed ID: 26855569
[TBL] [Abstract][Full Text] [Related]
29. Engineering Strategies for Oral Therapeutic Enzymes to Enhance Their Stability and Activity.
Lapuhs P; Fuhrmann G
Adv Exp Med Biol; 2019; 1148():151-172. PubMed ID: 31482499
[TBL] [Abstract][Full Text] [Related]
30. Advances in modification and delivery of nucleic acid drugs.
Wang J; Tan M; Wang Y; Liu X; Lin A
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
[TBL] [Abstract][Full Text] [Related]
31. Adapted nano-carriers for gastrointestinal defense components: surface strategies and challenges.
Wang W; Yan X; Li Q; Chen Z; Wang Z; Hu H
Nanomedicine; 2020 Oct; 29():102277. PubMed ID: 32730981
[TBL] [Abstract][Full Text] [Related]
32. Polymeric nanoparticle technologies for oral drug delivery.
Pridgen EM; Alexis F; Farokhzad OC
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1605-10. PubMed ID: 24981782
[TBL] [Abstract][Full Text] [Related]
33. A review of biodegradable polymeric systems for oral insulin delivery.
Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
[TBL] [Abstract][Full Text] [Related]
34. Polymeric particulates to improve oral bioavailability of peptide drugs.
Delie F; Blanco-Príeto MJ
Molecules; 2005 Jan; 10(1):65-80. PubMed ID: 18007277
[TBL] [Abstract][Full Text] [Related]
35. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.
Afonin KA; Dobrovolskaia MA; Ke W; Grodzinski P; Bathe M
Adv Drug Deliv Rev; 2022 Feb; 181():114081. PubMed ID: 34915069
[TBL] [Abstract][Full Text] [Related]
36. Recent progress of micro/nanomotors to overcome physiological barriers in the gastrointestinal tract.
Zhang S; Zhu C; Huang W; Liu H; Yang M; Zeng X; Zhang Z; Liu J; Shi J; Hu Y; Shi X; Wang ZH
J Control Release; 2023 Aug; 360():514-527. PubMed ID: 37429360
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary drug delivery: a role for polymeric nanoparticles?
d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
[TBL] [Abstract][Full Text] [Related]
38. Polymeric nanoparticles (PNPs) for oral delivery of insulin.
Wang Y; Li H; Rasool A; Wang H; Manzoor R; Zhang G
J Nanobiotechnology; 2024 Jan; 22(1):1. PubMed ID: 38167129
[TBL] [Abstract][Full Text] [Related]
39. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
Diab R; Jaafar-Maalej C; Fessi H; Maincent P
AAPS J; 2012 Dec; 14(4):688-702. PubMed ID: 22767270
[TBL] [Abstract][Full Text] [Related]
40. Oral drug delivery with nanoparticles into the gastrointestinal mucosa.
Liu J; Leng P; Liu Y
Fundam Clin Pharmacol; 2021 Feb; 35(1):86-96. PubMed ID: 32749731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
